Picture of Kalaris Therapeutics logo

KLRS — Kalaris Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Allovir Inc Notifies SVB Securities That It Was Terminating Prospectus Supplement

June 21 (Reuters) - Allovir Inc  ALVR.O :
    * ALLOVIR INC - NOTIFIED SVB SECURITIES THAT IT WAS
SUSPENDING ITS
USE OF AND TERMINATING PROSPECTUS SUPPLEMENT
    * ALLOVIR: PROSPECTUS SUPPLEMENT RELATED TO POTENTIAL
ISSUANCE
FROM TIME TO TIME OF CO'S COMMON STOCK PURSUANT TO SALES
AGREEMENT DATED AUGUST 6, 2021

Source: (https://shorturl.at/CHIJ7)
Further company coverage:  ALVR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kalaris Therapeutics

See all news